In a welcome move, CVS Health saw its Relative Strength Rating improve from 63 to 74 on Wednesday.
This unique rating measures technical performance by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.
Over 100 years of market history reveals that the best-performing stocks often have an RS Rating of over 80 in the early stages of their moves. See if CVS Health can continue to show renewed price strength and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
CVS Health is working on a cup with handle with a 67.34 entry. See if it can clear the breakout price in volume at least 40% above average.
While revenue growth fell last quarter from 6% to 4%, the bottom line grew -44%, up from -51% in the prior report.
CVS Health holds the No. 10 rank among its peers in the Medical-Managed Care industry group. Alignment Healthcare, Cigna Group and Molina Healthcare are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
